Canopy Growth (CGC) Cash & Equivalents (2017 - 2025)
Canopy Growth's (CGC) quarterly Cash & Equivalents came in at $145.1 million in Q4 2025, up 25.18% year-on-year from $115.9 million in Q4 2024, and up 54.23% quarter-over-quarter from $94.1 million in Q3 2025.
Canopy Growth (CGC) Cash & Equivalents (2017 - 2025) Analysis & Trends
Canopy Growth has disclosed Cash & Equivalents across 9 years of filings, most recently posting $145.1 million for Q4 2025.
- Cash & Equivalents for Q4 2025 came in at $145.1 million, up 25.18% year-over-year; the trailing twelve-month figure through Dec 2025 was $145.1 million (up 25.18% YoY), and the FY2025 annual result was $79.2 million, up 94.55% from the prior year.
- Cash & Equivalents came in at $145.1 million for Q4 2025 at Canopy Growth, up from $94.1 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $912.3 million in Q1 2021 to a low of $90935.8 in Q2 2025.
- The 5-year median for Cash & Equivalents is $289.1 million (2023), against an average of $334.3 million.
- Across the five-year window, Cash & Equivalents surged 97.17% in 2021 and sank 99.94% in 2025, its largest moves.
- Canopy Growth's Cash & Equivalents stood at $488.0 million in 2021, then declined by 9.71% to $440.6 million in 2022, then tumbled by 76.21% to $104.9 million in 2023, then climbed by 10.54% to $115.9 million in 2024, then rose by 25.18% to $145.1 million in 2025.
- The last three Cash & Equivalents figures came in at $145.1 million (Q4 2025), $94.1 million (Q3 2025), and $90935.8 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 1.28 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 40.42 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 266.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 351.55 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 222.27 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 498.58 Mn |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | 145.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 145.08 Mn |
| Sep 30, 2025 | 94.07 Mn |
| Jun 30, 2025 | 90,935.77 |
| Mar 31, 2025 | 79.23 Mn |
| Dec 31, 2024 | 115.90 Mn |
| Sep 30, 2024 | 167.44 Mn |
| Jun 30, 2024 | 140.49 Mn |
| Mar 31, 2024 | 40.72 Mn |
| Dec 31, 2023 | 104.85 Mn |
| Sep 30, 2023 | 181.24 Mn |
| Jun 30, 2023 | 396.99 Mn |
| Mar 31, 2023 | 493.89 Mn |
| Dec 31, 2022 | 440.64 Mn |
| Sep 30, 2022 | 572.54 Mn |
| Jun 30, 2022 | 603.55 Mn |
| Mar 31, 2022 | 612.64 Mn |
| Dec 31, 2021 | 488.02 Mn |
| Sep 30, 2021 | 641.58 Mn |
| Jun 30, 2021 | 455.45 Mn |
| Mar 31, 2021 | 912.29 Mn |